◆ Market Terminal AILook up a stock

Becton, Dickinson and Company (BDX)

Healthcare · Medical - Instruments & Supplies · Large-cap · updated October 16, 2026

NOT A BUY TODAY
What this means. Becton, Dickinson and Company is an average business by our measures, its shares look fairly priced, and its share price has been doing well.
Value54
Quality46
Price trend80
Overall57
674 of 2764rank among the US stocks we score (our core model buys the top 15)
76%of US stocks we score rank below it

Scores are 0 to 100 against every US stock we track; 50 is average. Recomputed after every US market close.

The business in numbers

Fiscal year to September 2025, from the company's annual filing with the SEC.

Salesyearly sales$21.8B
Sales growthchange from the year before+8.2%
Gross marginshare of sales left after the direct cost of what it sells45.4%
Operating marginshare of sales left after running the business11.8%
Net marginshare of sales kept as profit7.7%
Return on invested capitalprofit made on each $100 put into the business4.8%
Return on equityprofit vs. shareholders' accounting value6.6%
Debt / equitydebt vs. shareholders' accounting value0.67
Interest coverhow many times profit covers interest payments4.2x
Change in share countnegative = the company is buying back its shares-0.9%

Insider trades, last 90 days

1 insider sold $12K (all under pre-arranged plans) on the open market.

Feld MichaelEVP, Chief Revenue OfficerSold (plan)Jul 2775 shat $157.13 · $12K

From Form 4 filings with the SEC. Open-market trades only. "Plan" = a sale set up in advance under a 10b5-1 plan, usually routine.

Higher-scoring in the same industry

Interactive lookupGet the Ledger every Monday

Not financial advice. Research and education only: the same view for everyone, with no regard to your circumstances. Past results do not predict future ones. Decide for yourself or with a licensed adviser. Terms · Privacy